Projected Income Statement: Orange

Forecast Balance Sheet: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 24,269 25,298 27,002 22,482 22,526 39,767 38,636 36,686
Change - 4.24% 6.74% -16.74% 0.2% 76.54% -2.84% -5.05%
Announcement Date 2/17/22 A 2/16/23 A 2/15/24 A 2/13/25 A 2/18/26 A - - -
1EUR in Million
Estimates

Cash Flow Forecast: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 7,660 7,371 6,815 6,425 6,208 7,352 7,506 7,468
Change - -3.77% -7.54% -5.72% -3.38% 18.43% 2.09% -0.51%
Free Cash Flow (FCF) 1 3,576 3,864 5,239 3,770 4,572 4,194 4,898 5,334
Change - 8.05% 35.58% -28.04% 21.27% -8.27% 16.8% 8.89%
Announcement Date 2/17/22 A 2/16/23 A 2/15/24 A 2/13/25 A 2/18/26 A - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Orange

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 29.55% 29.82% 29.54% 30.08% 30.87% 32.14% 33.06% 33.65%
EBIT Margin (%) 18.74% 13.67% 12.71% 13.63% 11.31% 13.75% 14.04% 14.4%
EBT Margin (%) 4.09% 8.93% 8.53% 10.57% 5.47% 10.43% 10.64% 11.34%
Net margin (%) 0.55% 4.94% 5.53% 5.84% 1.33% 6.13% 6.31% 6.78%
FCF margin (%) 8.41% 8.89% 11.87% 9.36% 11.32% 9.39% 9.99% 10.68%
FCF / Net Income (%) 1,534.76% 180.06% 214.71% 160.43% 849.81% 153.2% 158.34% 157.58%

Profitability

        
ROA 0.22% 1.97% 2.22% 2.2% 0.51% 2.34% 2.52% 2.78%
ROE 6.1% 6.69% 7.67% 7.39% 1.75% 8.86% 8.93% 10.01%

Financial Health

        
Leverage (Debt/EBITDA) 1.93x 1.95x 2.07x 1.86x 1.81x 2.77x 2.38x 2.18x
Debt / Free cash flow 6.79x 6.55x 5.15x 5.96x 4.93x 9.48x 7.89x 6.88x

Capital Intensity

        
CAPEX / Current Assets (%) 18.01% 16.96% 15.45% 15.96% 15.37% 16.46% 15.31% 14.96%
CAPEX / EBITDA (%) 60.96% 56.86% 52.28% 53.06% 49.78% 51.2% 46.3% 44.45%
CAPEX / FCF (%) 214.21% 190.76% 130.08% 170.42% 135.78% 175.31% 153.23% 140%

Items per share

        
Cash flow per share 1 4.228 4.182 4.531 3.833 4.052 3.87 4.257 4.342
Change - -1.09% 8.35% -15.4% 5.72% -4.5% 10% 2%
Dividend per Share 1 0.7 0.7 0.7 0.72 0.75 0.7872 0.8196 0.8513
Change - 0% 0% 2.86% 4.17% 4.96% 4.11% 3.87%
Book Value Per Share 1 12.16 11.96 11.97 11.95 11.19 11.75 12.44 12.96
Change - -1.66% 0.1% -0.14% -6.39% 5.06% 5.86% 4.19%
EPS 1 - 0.73 0.85 0.82 0.14 1.016 1.141 1.242
Change - - 16.44% -3.53% -82.93% 625.87% 12.31% 8.83%
Nbr of stocks (in thousands) 2,631,971 2,657,122 2,659,182 2,658,153 2,658,600 2,659,283 2,659,283 2,659,283
Announcement Date 2/17/22 A 2/16/23 A 2/15/24 A 2/13/25 A 2/18/26 A - - -
1EUR
Estimates
2026 *2027 *
P/E Ratio 17.5x 15.6x
PBR 1.51x 1.43x
EV / Sales 1.95x 1.75x
Yield 4.43% 4.61%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
17.76EUR
Average target price
19.02EUR
Spread / Average Target
+7.09%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!